A 10-year agreement between the University of Pittsburgh and Parallel will initially focus on medical cannabis and the symptoms of sickle cell disease symptoms.

 

Read more at https://www.bizjournals.com/pittsburgh/news/2020/08/05/university-of-pittsburgh-grant.html